Patent ID: 9585859
Date: 2017-03-07
CPC Classifications: A61K,G01N

Claim:
1. A method of lowering triglycerides in a subject on statin therapy having baseline fasting triglycerides of about 200 mg/dl to less than 500 mg/dl, the method comprising determining a baseline fasting triglyceride level and a baseline fasting apolipoprotein B (“Apo B”) level of about 217 mg/dl or about 227 mg/dl associated with the subject; and thereafter administering to the subject about 2 grams or about 4 grams per day of ethyl eicosapentaenoate, wherein after the administering an Apo B level associated with the subject is lower than the baseline fasting Apo B level compared to a second subject who has received statin therapy but not the ethyl eicosapentaenoate.